HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increasing survival of dogs subjected to hemorrhagic shock by administration of fructose 1-6 diphosphate.

Abstract
Previous reports from this laboratory described animal experiments in which intravenous administration of fructose 1-6 diphosphate (FDP) at the onset of hypovolemia, toxemia, and trauma effected improvement in hemodynamic and metabolic parameters, attenuation of tissue damage, and a significant increase in survival. The obvious question remained: Would this agent be as effective if administered after the onset of the shock syndrome? Thus 72 anesthetized dogs were subjected to normotensive hemorrhagic shock and were subsequently treated with FDP at 30 minutes, 1 hour, 90 minutes, and 2 hours after exsanguination. Analysis of the results (as compared with vehicle-treated controls) revealed evidence of improved cardiac output and arterial pressure (p less than 0.02), conservation of effective circulatory volume, better oxygen utilization, and a significant increase in survival (p less than 0.0001). These results, in conjunction with earlier experimental and recent clinical data, indicate that the therapeutic effect of FDP in ischemic and hypoperfusion states is in part metabolically mediated by the augmentation of carbohydrate utilization. Prevention of tissue injury is in part due to the inhibition of generation of oxygen-derived free radicals by neutrophils.
AuthorsA K Markov, J Terry 3rd, T Z White, R H Didlake, H K Hellems
JournalSurgery (Surgery) Vol. 102 Issue 3 Pg. 515-27 (Sep 1987) ISSN: 0039-6060 [Print] United States
PMID2957808 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Fructosediphosphates
  • Hexosediphosphates
  • Phosphofructokinase-1
  • fructose-1,6-diphosphate
Topics
  • Animals
  • Dogs
  • Energy Metabolism (drug effects)
  • Fructosediphosphates (metabolism, therapeutic use)
  • Heart (drug effects)
  • Hexosediphosphates (therapeutic use)
  • Phosphofructokinase-1 (metabolism)
  • Respiration (drug effects)
  • Shock, Hemorrhagic (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: